These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
5645 related items for PubMed ID: 2635671
1. [The effect of antitumor preparations on the energy metabolism of melanoma B16 in mice. A 31P-NMR method in vivo]. Shkarin PIu, Sokolova IS, Gorbacheva LB, Sibel'dina LA. Dokl Akad Nauk SSSR; 1989; 309(4):996-9. PubMed ID: 2635671 [No Abstract] [Full Text] [Related]
2. [A high-resolution 31P-NMR study of the disorders in the energy metabolic system of Ehrlich ascites cancer cells exposed to antitumor preparations]. Semenova NA, Shchelok EP, Ostrovskaia LA, Sibel'dina LA. Izv Akad Nauk SSSR Biol; 1991; (5):794-8. PubMed ID: 1795075 [Abstract] [Full Text] [Related]
3. [Antitumor activity of several new pentopyranosyl-chloroethylnitrosoureas]. Grouiller A, Navarro ML, Nonga B, Molière P, Santini R, Voulot C, Pacheco H. C R Seances Soc Biol Fil; 1987; 181(2):128-36. PubMed ID: 2957032 [Abstract] [Full Text] [Related]
4. Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways. Morvan D, Demidem A. Cancer Res; 2007 Mar 01; 67(5):2150-9. PubMed ID: 17332345 [Abstract] [Full Text] [Related]
5. [31P-NMR study of the dynamics of energy metabolism in hepatoma 22-a cells exposed to antitumor preparations]. Dubinskiĭ VZ, Semenova NA, Sibel'dina LA. Dokl Akad Nauk SSSR; 1985 Mar 01; 281(1):180-3. PubMed ID: 3996197 [No Abstract] [Full Text] [Related]
6. [Changes in DNA synthesis and the pool of phosphorus-containing metabolites in tumor and normal cells in the process of melanoma B16 growth. Use of the high-resolution 31P-NMR method in in vivo experiments]. Sokolova IS, Shkarin PIu, Dubinskiĭ VZ, Samoĭlenko AA, Sibel'dina LA. Dokl Akad Nauk SSSR; 1983 Mar 01; 271(1):223-6. PubMed ID: 6617462 [No Abstract] [Full Text] [Related]
7. Combined methionine deprivation and chloroethylnitrosourea have time-dependent therapeutic synergy on melanoma tumors that NMR spectroscopy-based metabolomics explains by methionine and phospholipid metabolism reprogramming. Guénin S, Morvan D, Thivat E, Stepien G, Demidem A. Nutr Cancer; 2009 Mar 01; 61(4):518-29. PubMed ID: 19838924 [Abstract] [Full Text] [Related]
8. [Anti-invasive and anti-metastatic effect of ampelopsin on melanoma]. Zheng HQ, Liu DY. Ai Zheng; 2003 Apr 01; 22(4):363-7. PubMed ID: 12703989 [Abstract] [Full Text] [Related]
9. Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples. Morvan D, Demidem A, Papon J, De Latour M, Madelmont JC. Cancer Res; 2002 Mar 15; 62(6):1890-7. PubMed ID: 11912170 [Abstract] [Full Text] [Related]
10. Cystemustine induces redifferentiation of primary tumors and confers protection against secondary tumor growth in a melanoma murine model. Demidem A, Morvan D, Papon J, De Latour M, Madelmont JC. Cancer Res; 2001 Mar 01; 61(5):2294-300. PubMed ID: 11280801 [Abstract] [Full Text] [Related]
11. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth. Gil-Ad I, Shtaif B, Levkovitz Y, Nordenberg J, Taler M, Korov I, Weizman A. Oncol Rep; 2006 Jan 01; 15(1):107-12. PubMed ID: 16328041 [Abstract] [Full Text] [Related]
12. Response of melanoma tumor phospholipid metabolism to chloroethyle nitrosourea: a high resolution proton NMR spectroscopy study. Morvan D, Demidem A, Madelmont JC. Pathol Biol (Paris); 2003 Jul 01; 51(5):256-9. PubMed ID: 14567189 [Abstract] [Full Text] [Related]
13. Antitumor efficiency of novel fluoro-substituted 6-amino-2-phenylbenzothiazole hydrochloride salts in vitro and in vivo. Stojkovic R, Karminski-Zamola G, Racane L, Tralic-Kulenovic V, Glavas-Obrovac L, Ivankovic S, Radacic M. Methods Find Exp Clin Pharmacol; 2006 Jul 01; 28(6):347-54. PubMed ID: 16894403 [Abstract] [Full Text] [Related]
14. Experimental antitumor activity and toxicity of the selected triazolo- and imidazoacridinones. Kuśnierczyk H, Chołody WM, Paradziej-Lukowicz J, Radzikowski C, Konopa J. Arch Immunol Ther Exp (Warsz); 1994 Jul 01; 42(5-6):415-23. PubMed ID: 8572901 [Abstract] [Full Text] [Related]
15. [The potential for enhancing the therapeutic efficacy of antitumor preparations]. Konovalova NP, Volkova LM, Klochko AV. Izv Akad Nauk SSSR Biol; 1989 Jul 01; (3):466-8. PubMed ID: 2760333 [Abstract] [Full Text] [Related]
16. In vivo cytotoxicity and antineoplastic activity of a transferrin-daunorubicin conjugate. Lemieux P, Pagé M, Noël C. In Vivo; 1992 Jul 01; 6(6):621-7. PubMed ID: 1296812 [Abstract] [Full Text] [Related]
17. Potentiated antitumor effects of interleukin 12 and interferon alpha against B16F10 melanoma in mice. Dabrowska A, Giermasz A, Gołab J, Jakóbisiak M. Neoplasma; 2001 Jul 01; 48(5):358-61. PubMed ID: 11845979 [Abstract] [Full Text] [Related]
18. In vivo 31P MRS in new antineoplastic agents evaluation on experimental tumor models. Le Moyec L, Naruse S, Higuchi T, Hirakawa K, Watari H, de Certaines JD, Roques BP. Cancer Biochem Biophys; 1988 Jul 01; 10(1):31-45. PubMed ID: 2465078 [Abstract] [Full Text] [Related]
19. Granulocyte colony-stimulating factor demonstrates antitumor activity in melanoma model in mice. Gołab J, Zagozdzon R, Stokłosa T, Kaca A, Dabrowska A, Giermasz A, Feleszko W, Jakóbisiak M. Neoplasma; 1998 Jul 01; 45(1):35-9. PubMed ID: 9605000 [Abstract] [Full Text] [Related]
20. [NMR tomography of experimental malignant neoplasms in vivo]. Iushmanov VE, Iantsen VI, Pliushch AL, Sokolova IS, Gorbacheva LB. Dokl Akad Nauk SSSR; 1985 Jul 01; 282(3):734-6. PubMed ID: 4028946 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]